Tech Center 1600 • Art Units: 1641 1643 1644 1646 1647 1653 1654
This examiner grants 64% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18020611 | TARGETED PROTEIN DEGRADATION IN THERAPEUTIC CELLS | Final Rejection | The Regents of the University of California |
| 17863149 | METHODS FOR TREATING VIRAL INFECTIONS | Non-Final OA | The Regents of The University of California |
| 18691410 | METHODS OF AMPLIFYING TUMOR-REACTIVE IMMUNE POPULATIONS USING ORGANOIDS | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 17793024 | PERICYTE-SPARING THERAPY | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18044482 | ENGINEERED IMMUNE CELLS FOR REAGENT DELIVERY | Non-Final OA | REGENTS OF THE UNIVERSITY OF MINNESOTA |
| 17765043 | ELUTION OF MONOCLONAL ANTIBODIES IN PROTEIN A AFFINITY CHROMATOGRAPHY | Non-Final OA | Merck Patent GmbH |
| 17800387 | CAR T CELLS TARGETING THE INTEGRIN ALPHAV BETA3 EXHIBIT ROBUST ANTI-TUMOR RESPONSES AGAINST GLIOMAS AND OTHER SOLID TUMOR MALIGNANCIES | Final Rejection | University of Virginia Patent Foundation |
| 17923029 | METHODS FOR TREATING OR REDUCING THE SEVERITY OF A VIRAL INFECTION | Non-Final OA | Washington University |
| 17904706 | Bispecific GD2 and B7H3 Binding Molecules and Methods of Use | Non-Final OA | WISCONSIN ALUMNI RESEARCH FOUNDATION |
| 16547907 | EXPANSION OF HPSC-DERIVED GRANULOCYTIC AND LYMPHOID PROGENITORS WITH UM171 | Final Rejection | Wisconsin Alumni Research Foundation |
| 18059369 | MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF | Final Rejection | Seattle Children's Hospital d/b/a Seattle Children's Research Institute |
| 18277367 | TRUNCATED DOMAIN IV EGFR AND USES THEREOF | Final Rejection | CITY OF HOPE |
| 17789930 | METHODS OF MAKING AND USING REGULATORY T CELLS AND EFFECTOR T CELLS HAVING CHIMERIC ANTIGEN RECEPTORS TARGETED TO CD6, CD19, AND/OR AN IL-13R FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCERS | Non-Final OA | CITY OF HOPE |
| 18424298 | BIOMARKERS AND METHODS FOR MEASURING AND MONITORING JUVENILE IDIOPATHIC ARTHRITIS ACTIVITY | Non-Final OA | Laboratory Corporation of America Holdings |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy